Phio Pharmaceuticals Corp.

DB:44R0 Stock Report

Market Cap: €5.3m

Phio Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bob Bitterman

Chief executive officer

US$172.9k

Total compensation

CEO salary percentage18.4%
CEO tenureless than a year
CEO ownership0.2%
Management average tenureno data
Board average tenure6.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bob Bitterman's remuneration changed compared to Phio Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022US$173kUS$32k

-US$11m

Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$13m

Dec 31 2021US$78kn/a

-US$13m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$11m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$45kn/a

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$9m

Mar 31 2020n/an/a

-US$9m

Dec 31 2019US$64kn/a

-US$9m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018US$53kn/a

-US$7m

Sep 30 2018n/an/a

-US$8m

Jun 30 2018n/an/a

-US$9m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$36kn/a

-US$12m

Sep 30 2017n/an/a

-US$15m

Jun 30 2017n/an/a

-US$15m

Mar 31 2017n/an/a

-US$14m

Dec 31 2016US$38kn/a

-US$11m

Compensation vs Market: Bob's total compensation ($USD172.93K) is below average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: Bob's compensation has increased whilst the company is unprofitable.

CEO

Bob Bitterman (71 yo)

less than a year

Tenure

US$172,926

Compensation

Mr. Robert J. Bitterman, also known as Bob, serves as Chairman at Phio Pharmaceuticals Corp. since 2012 and has been its President and Chief Executive Officer since February 2023. Mr. Bitterman served as...

Board Members

NamePositionTenureCompensationOwnership
Robert Bitterman
President10.8yrsUS$172.93k0.19%
$ 10.1k
Geert Cauwenbergh
Director11yrsUS$129.86k0.18%
$ 9.6k
Patricia Bradford
Independent Directorless than a yearUS$42.29kno data
James Griffin
Member of Scientific Advisory Board6.2yrsno datano data
Curtis Lockshin
Independent Director10yrsUS$47.36k0.11%
$ 5.9k
Pamela Pavco
Member of Scientific Advisory Board5.9yrsno datano data
Rolf Kiessling
Member of Scientific Advisory Board6.2yrsno datano data
Robert Ferrara
Lead Independent Director3.5yrsUS$57.99k0.17%
$ 8.8k
Jonathan Freeman
Independent Director5.8yrsUS$39.86k0.11%
$ 5.9k

6.2yrs

Average Tenure

69yo

Average Age

Experienced Board: 44R0's board of directors are considered experienced (6.2 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.